-
241
SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia
Published 2022-11-01Subjects: Get full text
Article -
242
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib
Published 2009-03-01“…The purpose of this review is to summarize the pre-clinical and clinical data on nilotinib in patients with CML who have failed prior therapy with IM or dasatinib.Keywords: nilotinib, chronic myeloid leukemia, imatinib…”
Get full text
Article -
243
A Case with Neurofibromatosis and Chronic Myeloid Leukemia in Blastic Crisis Treated with Imatinib
Published 2014-03-01Subjects: Get full text
Article -
244
Nilotinib-Induced Acute Interstitial Nephritis during the Treatment of Chronic Myeloid Leukemia
Published 2021-12-01“…We report a case of a 39-year-old man with acute kidney injury that developed after nilotinib treatment for chronic myeloid leukemia (CML). The renal function of the patient decreased during treatment with nilotinib but improved when treatment was discontinued due to neutropenia. …”
Get full text
Article -
245
Effects of nilotinib on platelet function in patients with chronic myeloid leukemia in chronic phase
Published 2019-01-01“…Patients and methods: This study was conducted on 42 patients diagnosed as Chronic Phase of Chronic Myeloid Leukemia based on clinical, morphological and cytogenetic study. …”
Get full text
Article -
246
Subjective intermittent colour vision loss as the initial presentation of chronic myeloid leukemia
Published 2020-09-01“…Purpose: To report a case of subjective intermittent loss of bilateral colour vision and episodic white-out vision in a patient with undiagnosed chronic myeloid leukemia (CML). Observations: A patient initially diagnosed with diabetic retinopathy presented with a chief complaint of subjective intermittent loss of colour vision in both eyes, as well as intermittent bilateral white-out vision. …”
Get full text
Article -
247
Definition, Epidemiology, Pathophysiology, and Essential Criteria for Diagnosis of Pediatric Chronic Myeloid Leukemia
Published 2021-02-01“…Depending on the analytical tool applied, the hallmarks of chronic myeloid leukemia (CML) are the Philadelphia Chromosome and the resulting mRNA fusion transcript BCR-ABL1. …”
Get full text
Article -
248
Chronic myeloid leukemia in India: The poster child of translational medicine needs help!
Published 2013-01-01Get full text
Article -
249
Chronic myeloid leukemia with solitary extramedullary bone deposit: A unique presentation
Published 2021-01-01Subjects: Get full text
Article -
250
Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia
Published 2020-08-01Subjects: “…chronic myeloid leukemia, transcript type, e13a2, e14a2, treatment-free remission…”
Get full text
Article -
251
Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendations
Published 2020-10-01“…With survival expectation that of age-matched controls and given excellent response and worldwide access to tyrosine kinase inhibitors (TKI), family planning is increasingly important for a considerable fraction of patients with chronic myeloid leukemia (CML). The potential for therapy discontinuation (“treatment free remission”) can afford the opportunity for a CML patient in deep response to plan and carry a pregnancy to full term without any therapeutic interventions. …”
Get full text
Article -
252
First-line therapy of chronic myeloid leukemia – focus on dasatinib
Published 2012-04-01“…This activity has allowed dasatinib to emerge as one of the most effective agents in the treatment of chronic myeloid leukemia (CML), and dasatinib has become the third drug over the past 10 years to be FDA approved for first line therapy in this setting. …”
Get full text
Article -
253
BCR-ABL gene amplification in patients with chronic myeloid leukemia and imatinib resistance
Published 2022-11-01Subjects: “…chronic myeloid leukemia…”
Get full text
Article -
254
Male Fertility and Fatherhood in Chronic Myeloid Leukemia: Current Understanding and Future Perspectives
Published 2024-02-01“…Chronic myeloid leukemia (CML), while traditionally a disease of the elderly, has recently risen in incidence among younger patients. …”
Get full text
Article -
255
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
Published 2018-02-01“…Abstract The introduction of ABL Tyrosine Kinase Inhibitors (TKIs) has significantly improved the outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory hematological, cytogenetic and molecular remissions. …”
Get full text
Article -
256
Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront
Published 2020-06-01Subjects: Get full text
Article -
257
Abnormal eosinophils with immature eosinophilic granules in chronic myeloid leukemia in accelerated phase
Published 2021-09-01Subjects: Get full text
Article -
258
Study of STAT3 Expression in Different Phases of Patients with Chronic Myeloid Leukemia
Published 2019-07-01Subjects: “…chronic myeloid leukemia…”
Get full text
Article -
259
Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia
Published 2018-01-01Subjects: “…chronic myeloid leukemia…”
Get full text
Article -
260
Spontaneous Remission in a Patient with Chronic Myeloid Leukemia: A Case Report
Published 2023-10-01Subjects: “…chronic myeloid leukemia…”
Get full text
Article